(Q60542077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Rocking the foundations of solid tumor growth by attacking the tumor's blood supply (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

A W Griffioen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

392-394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

Designing therapies that target tumor blood vessels

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901314-0

7 January 2021

10.1016/S0167-5699(98)01314-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9745201%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference